zum Inhalt
Header Image

03: Mythen der Life Sciences und ihre Konsequenzen

-
Hauptschule
Breakout / Working Group
in englischer Sprache

Gerade in den Life Sciences unterscheidet sich die Wahrnehmung – nicht nur einer wenig technikaffinen Öffentlichkeit, sondern oft auch von Entscheidungsträgern – von den aktuell vorhandenen Möglichkeiten und Gegebenheiten. Der Arbeitskreis soll anhand einiger pointierter Beispiele wesentliche Unterschiede zwischen Fakten und Fiktion herausarbeiten, Mythen entlarven, aber auch in jenen Fällen, wo Klischees zutreffen, diese bestätigen und Perspektiven zur Überwindung der entsprechenden Barrieren erörtern.

Professor of Virology and Head, Institute of Virology, University of Veterinary Sciences, Vienna
Co-Founder and Director, Critical I Limited, Banbury
Deputy Director, LIFE - Centre for Climate, Energy & Society, JOANNEUM RESEARCH Forschungsgesellschaft mbH, Graz
Partner, LSP - Life Sciences Partners, Munich
Head Development Fermentation, Sandoz GmbH, Kundl
Former Secretary General, EuropaBio - European Association for Bioindustries, Brussels
Vice Director and Programme Director, Cancer Cell Biology Programme, Spanish National Cancer Research Centre (CNIO), Madrid
Partner, Industry Leader Biotechnology for Central Europe, Ernst & Young Ltd., Basel
UNESCO Chair, Bioethics, Medical University of Vienna Chair
Abteilung für Technischwirtschaftliche Forschung, Bereich Wirtschaftspolitik, Innovation und Technologie, Bundesministerium für Wirtschaft und Arbeit, Wien Coordination

Ph.D. Dr. rer. nat. habil. Walter H. GÜNZBURG

Professor of Virology and Head, Institute of Virology, University of Veterinary Sciences, Vienna

 Received his Ph.D. in London on the control of eukaryotic gene expression by DNA methylation. After two postdoctoral positions in the U.S.A. and Switzerland, he became a group leader at the National Research Centre for Environment and Health (GSF), in Munich, Germany where he spent 8 years working on retroviral vector mediated gene therapy as well as continuing his basic studies on gene expression control in retroviruses. In 1996, he was appointed full Professor of Virology in Vienna, Austria and since then has headed the Research Institute of Virology and Biomedicine in Vienna. In 2004, he additionally became the head of the newly established Christian Doppler Laboratory for Gene Therapeutic Vector Development, working in close collaboration with Biotech and Pharmaceutical industries to develop new retroviral vectors and cell therapy approaches for the treatment of solid tumours. In 2007 the Christian Doppler Society opened a foreign module focusing on virology and nanotechnology in Singapore under his leadership. Over the last ten years Prof Günzburg has been actively involved in European ethics and regulatory affairs in the fields of both xenotransplantation and gene therapy.

John HODGSON

Co-Founder and Director, Critical I Limited, Banbury

 Co-founder and Director of Critical I, a business development and business intelligence consultancy, specialising in the life sciences. Critical I supplies data and analysis of the life science sector to government ministries, regional development agencies, and other clients. Critical I also helps deserving early stage European biotechnology companies with business development, marketing, and fund raising.
 His assignments in the last two years include providing regulatory advice to an agrochemicals multinational; providing market analysis and positioning advice to a filtration technology company entering the biotechnology market; identifying potential acquisition targets for a leading quoted bioinformatics company; and evaluating potential investments on behalf of a number of the world's largest venture capital funds. John trained as a microbiologist and has followed the biotechnology sector since the early 80s.
 Since 1997, he has been a consultant in the field, advising biotech start-ups, venture capital funds, major companies in the pharmaceutical and agrochemical sector, scientific foundations, university tech transfer organisations, and European Commission and UK Government bodies on aspects of biotechnology ranging from business planning, fundraising, risk management and technology trends.
 Before 1997, John was a science and business writer as Senior Editor with Nature Biotechnology, the leading journal in the field, and before that Editor of Trends in Biotechnology. He is still Editor at Large of Nature Biotechnology, contributing occasional editorials and sage advice.
 In 2002-2003 John was Special Adviser to the UK Parliamentary Trade and Industry Select Committee in its enquiry into the UK biotechnology sector. He is also adviser to BioVision, the World Life Sciences Forum in Lyon, and an organiser of the first Biovision Nobel Days.

Dipl.-Ing. Dr. techn. Gerfried JUNGMEIER

Deputy Director, LIFE - Centre for Climate, Energy & Society, JOANNEUM RESEARCH Forschungsgesellschaft mbH, Graz

since 1993 Scientist at JOANNEUM RESEARCH
2000 Ph.D., "Greenhouse Gas Balance of Bioenergy Systems"
2002-2007 Chair Person, COST Action E31 "Management of Recovered Wood"
since 2006 Lecturer, "Ecological Resource Management", Vienna University of Technology
2007-2015 National Team Leader, IEA Bioenergy Task 42 "Biorefinery"
since 2011 Operating Agent, IEA HEV Task 30 "Life Cycle Assessment of Electric Vehicles"
since 2015 Operating Agent, IEA HEV Task 33 "Battery Electric Buses"
since 2016 Leader, CCCA Working Group "Consumption based Greenhouse Gas Accounting"

Dr. Jörg NEERMANN

Partner, LSP - Life Sciences Partners, Munich

1993-1996 Ph.D. thesis (Dr. rer. nat.) at Technical University Carolo-Wilhelmina at Brunswick, German Research Center for Biotechnology (GBF) in parallel studies in economics at Technical University Carolo-Wilhelmina at Brunswick
1996-1998 Atlas Venture
1998-2006 DVC Deutsche Venture Capital
2002-2006 Managing Partner at DVC
since 2007 Partner at LSP Life Science Partners; board member of numerous Life Science Companies

Dr. Johan VANHEMELRIJCK

Former Secretary General, EuropaBio - European Association for Bioindustries, Brussels

1989-2002 Secretary General, European Federation of Animal Health (FEDESA)
2002 Senior Director Worldwide Industry Affairs for Pharmacia Animal Health
since 2003 CEO of HI&PP Consult
2004-2008 Secretary General of EuropaBio, the European Association for Bioindustries

Dr. Erwin F. WAGNER

Vice Director and Programme Director, Cancer Cell Biology Programme, Spanish National Cancer Research Centre (CNIO), Madrid

1979-1983 Max-Kade Fellow and Research Associate, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA (U.S.A.) with Dr. B. Mintz
1983-1988 Group Leader, European Molecular Biology Laboratory, Heidelberg, Germany
1988-1997 Senior Scientist, Research Institute of Molecular Pathology (IMP), Vienna, Austria
1997-2008 Deputy Director, IMP, Vienna, Austria
since 2008 Vice Director and Programme Director, Cancer Cell Biology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

lic. oec. HSG Jürg ZÜRCHER

Partner, Industry Leader Biotechnology for Central Europe, Ernst & Young Ltd., Basel

1992 Diplomierter Wirtschaftsprüfer
1993-1994 Austauschjahr bei Ernst & Young in den USA
1998 Ernennung zum Partner bei Ernst & Young Schweiz
2001 Verantwortlicher für den Biotech-Sektor Schweiz
2005 Verantwortung für den Biotech-Sektor Zentraleuropa
seit 2005 Mitglied des Global Biotech Advisory Panel von Ernst & Young Global

Dr. Christiane DRUML

UNESCO Chair, Bioethics, Medical University of Vienna

 Christiane Druml was born in Vienna and studied law at the University of Vienna. She is currently holding the UNESCO Chair on Bioethics at the Medical University of Vienna and also serves as Director of Ethics, Collections and History of Medicine of the Medical University of Vienna. Since 2016 she is Deputy Director & Key Researcher at the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases (LBI-RUD). 2007 she has been appointed President of the Austrian National Bioethics Commission by the Austrian Federal Chancellor. Furthermore, she is a member of the Medical Council of the Republic of Austria and serves in many international functions. From 2011 to 2015, she was Vice-Rector for Clinical Affairs at the Vienna Medical University. Before that she has been managing director of the Ethics Committee at the Vienna Medical University (1992-2011). Christiane Druml was Member of the International Bioethics Committee IBC of UNESCO from 2008 to 2015 and serves since 2006 as Austrian Member of the General Assembly of the "European and Developing Countries Clinical Trial Partnership- EDCTP". She has been awarded the Austrian Cross of Honour for Science and Arts, and was named Chevalier de la Légion d’Honneur in 2011.

Technologiegespräche

Timetable einblenden

21.08.2008

08:00 - 10:30Technologiebrunch gegeben von der Tiroler ZukunftsstiftungSocial
11:00 - 11:20Eröffnung durch das Europäische Forum AlpbachPlenary
11:20 - 12:00PlenumPlenary
12:00 - 12:30PlenumPlenary
13:00 - 13:45Ethik in der WissenschaftPlenary
13:45 - 14:30StammzellenPlenary
15:00 - 16:00Politik und Wissenschaft – Beratung durch WissenschaftPlenary
18:00 - 19:30BionikPlenary
19:30 - 21:30Empfang gegeben von Alcatel-Lucent Austria AGSocial

22.08.2008

07:00 - 14:00Arbeitskreis 01: Von der Grundlagenforschung zur ökonomischen WertschöpfungBreakout
07:00 - 14:00Arbeitskreis 02: Integrität in Forschung und WissenschaftBreakout
07:00 - 14:00Arbeitskreis 03: Mythen der Life Sciences und ihre KonsequenzenBreakout
07:00 - 14:00Arbeitskreis 04: Luftfahrt und UmweltBreakout
07:00 - 14:00Arbeitskreis 05: Think Tanks in ÖsterreichBreakout
07:00 - 14:00Arbeitskreis 06: Gender Mainstreaming in Forschung und Entwicklung. Realitäten wahrnehmen und visionär entscheidenBreakout
07:00 - 14:00Arbeitskreis 07: Erfolgsfaktor Mensch – Regionen im WettbewerbBreakout
07:00 - 14:00Arbeitskreis 08: Klimawandel – die Zukunft des VerkehrsBreakout
07:00 - 14:00Arbeitskreis 09: Governance der angewandten Forschung: Verantwortlichkeiten, Unabhängigkeit und RessourcenBreakout
07:00 - 14:00Arbeitskreis 10: Digital HealthcareBreakout
07:00 - 16:00Junior Alpbach – Wissenschaft und Technologie für junge MenschenBreakout
07:00 - 13:00Ö1 Kinderuni Alpbach – Wissenschaft und Technologie für KinderBreakout
08:00 - 14:00Arbeitskreis 11: Energieeffizienz – Chancen erkennen, Potenziale nutzenBreakout
08:00 - 13:00Sonderveranstaltung: Vom Stabilitätspakt für Südosteuropa zum Regionalen Kooperationsrat (RCC) – ein neuer Impuls für die europäische Perspektive des Westbalkans im Bereich Hochschulbildung und Forschung?Breakout
14:30 - 15:15Die Zukunft der Wissenschaft IPlenary
15:15 - 16:30Globaler Wettbewerb um globale TalentePlenary
18:00 - 19:30Informations- und Kommunikationsinfrastrukturen – Nervenzentren der modernen GesellschaftPlenary

23.08.2008

08:00 - 08:30Naturwissenschaftliche Bildung für eine technikorientierte GesellschaftPlenary
08:30 - 09:15Die Zukunft der Wissenschaft IIPlenary
09:15 - 09:45Die Zukunft der Umwelt und LandwirtschaftPlenary
10:00 - 10:15Junior Alpbach und Ö1 Kinderuni Alpbach 2008Plenary
10:15 - 11:15Improbable Research and the Ig Nobel prizePlenary
11:15 - 12:00Imbiss zum Abschluss der Veranstaltung, gegeben von AVL List GmbHSocial